HopeStage
Back to all studies
Not Yet RecruitingNCT07602335

Safety, Tolerability, and Pharmacokinetics of MCAM in Healthy Adult Participants

Medication studyAges 18–55United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
Overland ParkSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: October 22, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
24
Sponsor
The University of Texas Health Science Center at San Antonio
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT07602335
Official title
Show the full official title

A Phase 1, First-In-Human, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of MCAM in Randomized Healthy Adult Participants (Double-Blind)

Recruitment & locations

Not yet recruiting

Overland Park

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is The University of Texas Health Science Center at San Antonio, a university.

Does this study involve medication?

Yes. The study involves medication, including MCAM.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies